Finasteride

非那雄胺

Report date: 2025/07/29 15:07:35
NME

Base Information

Drug NameFinasteride
Drug Alias Name非那甾胺finasterideFinasteridas非那司提Finasteridi +[32] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductase
Therapy Area/IndicationsAlopeciaAcne VulgarisHemophilia B +[9] 
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryUnited States
Original Approved Date1992/06/19
Country/TerritoryCanadaUnited StatesAustralia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrganonEmsGemvax & Kael +[7] 
Inactive CompaniesCutia TherapeuticsRoswell Park Cancer InstituteMerck Frosst Canada Ltd +[15] 
Active IndicationsAlopeciaHemophilia BHemophilia A +[4] 
Inactive IndicationsAcne VulgarisHematuriaHemospermia +[5] 

Other Information

ATC CodeD11AX10G04CB01
Related LinksWikipediaDrugBankKEGG